Death in patients with tuberculosis and diabetes: Associated factors
Introduction
As a priority of Public Health, tuberculosis (TB) currently occupies a larger part of the world scenery. The UN (United Nations) estimates that one-third of the world’s population is infected with Mycobacterium tuberculosis. Brazil has ranked 15th among 22 leading nations with the highest TB incidence. According to the Ministry of Health, Brazil has an incidence of 41/100,000 inhabitants with the highest concentration in the states of São Paulo, Rio de Janeiro, and some states of Amazonas region [1], [2].
Considering the underreporting of TB in Brazil, the Ministry of Health estimated that 129,000 cases occur every year. Of these, 90,000 on average are reported, which highlights the concern over the outcome of treatment, especially in relation to high morbidity and mortality that are still currently observed [2], [3].
The disease has transmission and incidence characteristics related to socioeconomic factors and lifestyle habit. In addition, it has a direct action over the immune system. Thus, poverty, malnutrition, HIV infection, drug resistance, and diabetes mellitus have been increasingly identified as factors directly associated with the prevalence of TB [3], [4], [5].
In recent studies, Diabetes Mellitus has been pointed out as a risk factor for TB, as well as an associated factor in the severity and response to TB treatment. It is estimated that individuals living with diabetes mellitus are four times more likely to develop pulmonary TB [6], [7].
Diabetes Mellitus is also a public health priority. According to the World Health Organization, Diabetes Mellitus is the fifth leading cause of death worldwide, and it expects the number to double by 2030; furthermore, it indicates that new cases have increased, especially in developing countries like Brazil, in addition to late diagnosis, which is still part of the national current scenario [4], [7], [8].
Both TB and DM, when associated, deserve special attention. There is a number of evidence pointing out to their influence in TB treatment, even in the conversion of bacilloscopy, which may take 3–4 times longer than in non-diabetic patients [6], [9].
Since the 90s, the mortality rate has reduced by almost half in patients with TB. However, mortality is still a great concern, and its reduction has been occurring very slowly, especially due to the significant presence of death to TB and DM patients. Thus, when these two diseases occur simultaneously, there is a considerable interest on how they may influence each other in relation to mortality [7], [10].
The studies reporting the implications of the association between TB and DM in the outcome of TB are recent and very few. Both diseases are difficult to treat and control due to their direct action on the immune system and the need for a lifestyle change. The purpose of this study was to analyze the association of diabetes in cases of death in patients with tuberculosis. The study was carried out at a regional department of health in the state of São Paulo from 1996 to 2014.
Section snippets
Method
This is a descriptive and retrospective epidemiological study using secondary data of TB cases reported in the TBWEB information system from 1996 to 2014. The study period was chosen based on the creation of the TBWEB. Study population resides in the municipalities located in the area reached by the Regional Department of Health of Sao Jose do Rio Preto (DRS-XV), which is comprised of 102 municipalities and a total population of 1,472,771 inhabitants (IBGE 2015).
Data was retrieved from the
Results
After application of the inclusion and exclusion criteria, the number of TB cases in the area and study period was equal to 4820.
The variables used in the study presented 83% of completeness, then used 4447 cases in this study (excluded 17%). Patients with TB and DM corresponded to 306 cases (6,88%) of the 4447 cases of TB.
Table 1 shows the analyzed variables and your crude association with death in patients with tuberculosis.
It can be noted a predominance of individuals aged 20–59 and male
Discussion
Considering that 95% of TB cases occur in developing countries, especially in those with lower socioeconomic status and low Human Development Index (HDI), and of these, 98% of the cases led to death, we identify that future studies will be needed to confirm mortality and associated factors [12].
The goals of the World Health Organization through the Millennium Development Goals intend to reduce the prevalence of tuberculosis by 50% in 2015 and to less than 1 case per million inhabitants in 2050
Conflict of interest
There is no conflict of interest.
Financial support
This study didn’t have financial support.
Acknowledgments
We offer our deepest thanks to the institutions that provided technical support for the development and implementation of this study, especially the CVE – Epidemiology State Center XXIX and XXX.
References (19)
Mortality trends and risk of dying from pulmonary tuberculosis in the 7 socioeconomic regions and the 32 States of Mexico, 2000–2009
Arch Bronconeumol
(2015 Jan)- et al.
Causes of death in Japanese diabetics. A 20-year study of death certificates
J Chronic Dis
(1985) - et al.
Características clínicas e evolução de pacientes imunocomprometidos não HIV com diagnóstico intra-hospitalar de tuberculose
J Bras Pneumol
(2010) - et al.
Aspectos epidemiológicos da tuberculose pleural no estado de São Paulo (1998–2005)
J Bras Pneumol
(2009) Tuberculose: histórico, epidemiologia e imunologia, de a 1999, e co-infecção TB/HIV, de 1998 a 1999, Rio Grande do Sul – Brasil
Bol da Saúde
(1990)- Brasil. Ministério da Saúde. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Manual técnico para o...
Impact of diabetes and smoking on mortality in tuberculosis
PLoS One
(2013)Diabetes mellitus referido e fatores sociodemográficos, clínicos e epidemiológicos em pacientes adultos com tuberculose [manuscrito]Área de concentração: Saúde e Enfermagem
(2013)- et al.
Impacto do diabetes mellitus na mortalidade em síndromes coronarianas agudas
Arq Bras Endocrinol Metab
(São Paulo Mar. 2007)